Neuronetics (STIM) Other Non-Current Assets (2017 - 2026)
Neuronetics' (STIM) quarterly Other Non-Current Assets came in at $7.5 million in Q1 2026, down 11.84% year-on-year from $8.5 million in Q1 2025, and up 276.59% on a QoQ basis from $2.0 million in Q4 2025.
Neuronetics (STIM) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Neuronetics (STIM) has 10 years of Other Non-Current Assets data on file, last reported at $7.5 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 11.84% year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $7.5 million, a 11.84% decrease from a year earlier, with the FY2025 full-year figure at $2.0 million, up 3.07% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $7.5 million, up from $2.0 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for STIM reached as high as $8.7 million in Q3 2024 and fell as low as $1.9 million in Q3 2025.
- Historically, Other Non-Current Assets has averaged $5.2 million across 5 years, with a median of $4.9 million in 2024.
- Across the five-year window, Other Non-Current Assets jumped 239.77% in 2022 and sank 78.32% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $3.6 million in 2022, then soared by 129.63% to $8.4 million in 2023, then slumped by 77.03% to $1.9 million in 2024, then gained by 3.07% to $2.0 million in 2025, then soared by 276.59% to $7.5 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $7.5 million in Q1 2026, $2.0 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 7.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.46 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 8.47 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 8.73 Mn |
| Jun 30, 2024 | 5.05 Mn |
| Mar 31, 2024 | 4.88 Mn |
| Dec 31, 2023 | 8.37 Mn |
| Sep 30, 2023 | 4.09 Mn |
| Jun 30, 2023 | 7.98 Mn |
| Mar 31, 2023 | 7.64 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 7.31 Mn |
| Jun 30, 2022 | 3.25 Mn |
| Mar 31, 2022 | 2.84 Mn |
| Dec 31, 2021 | 2.22 Mn |
| Sep 30, 2021 | 2.15 Mn |
| Jun 30, 2021 | 1.98 Mn |